| Purchase price allocation |
| Issuance of 12,886,740 shares of common stock (voting and non-voting) valued at $3.66 per share |
|
$ |
47,165,468 |
|
| Transfer of two plasma collection centers |
|
|
12,621,844 |
|
| Total purchase price |
|
$ |
59,787,312 |
|
|
| Schedule of assets and liabilities assumed |
| Cash |
|
$ |
12,500,000 |
|
| Inventory |
|
|
8,197,354 |
|
| Land and buildings |
|
|
20,000,000 |
|
| Property and equipment |
|
|
8,209,800 |
|
| Assets held for sale |
|
|
845,389 |
|
| Other current assets |
|
|
795,553 |
|
| Trademark and other intangible rights to Nabi-HB |
|
|
4,100,046 |
|
| Right to intermediates |
|
|
907,421 |
|
| Customer contract |
|
|
1,076,557 |
|
| Goodwill |
|
|
3,529,509 |
|
| Liabilities assumed |
|
|
(374,317 |
) |
| Total purchase price |
|
$ |
59,787,312 |
|
|
| Pro forma information |
| |
|
Three Months Ended June 30, |
|
Six Months Ended June 30, |
| |
|
2017 |
|
2016 |
|
2017 |
|
2016 |
| Revenues: |
|
|
|
|
|
|
|
|
| As reported |
|
$ |
3,399,401 |
|
|
$ |
2,271,744 |
|
|
$ |
6,028,272 |
|
|
$ |
4,395,630 |
|
| Proforma |
|
$ |
10,569,393 |
|
|
$ |
22,704,653 |
|
|
$ |
24,292,042 |
|
|
$ |
44,336,311 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Net loss |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| As reported |
|
$ |
(9,036,495 |
) |
|
$ |
(6,012,335 |
) |
|
$ |
(15,573,458 |
) |
|
$ |
(10,624,804 |
) |
| Proforma |
|
$ |
(12,751,262 |
) |
|
$ |
(14,473,470 |
) |
|
$ |
(24,826,749 |
) |
|
$ |
(29,073,476 |
) |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Basic and diluted net loss per share: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| As reported |
|
$ |
(0.55 |
) |
|
$ |
(0.50 |
) |
|
$ |
(1.06 |
) |
|
$ |
(0.93 |
) |
| Proforma |
|
$ |
(0.49 |
) |
|
$ |
(0.58 |
) |
|
$ |
(0.96 |
) |
|
$ |
(1.20 |
) |
|